Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 15, 2022
Reporting Period: Fourth quarter and full year ended December 31, 2021.
Context: The filing announces financial results for the specified period and provides a business update. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references the announcement of financial results but does not contain the specific numerical data within the body of this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Note: Specific financial figures are located in the attached Exhibit 99.1 (Press Release), which is not included in the input text.
Material Changes
The filing text does not provide specific data to compare current period performance against prior comparable periods. It only confirms that results for Q4 and full-year 2021 were announced.
Guidance, Outlook, and Risks
Management Commentary: The Company provided a business update alongside the financial results, though the specific content of this update is not detailed in the filing text provided.
Legal Status: The information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Emerging Growth Company: The registrant is identified as an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net loss, and cash position figures for Q4 and FY 2021.
- Verify the details of the "business update" mentioned in the filing to understand operational progress.
- Confirm the impact of the emerging growth company election on financial reporting standards.
- Check subsequent filings for any updates to the financial results announced on March 15, 2022.